Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Environmental Health Perspectives
|
October 19, 2011
In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta
Charlotte S Wilhelm-Benartzi, E Andres Houseman, Matthew A Maccani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Implications of LINE1 methylation for bladder cancer risk in women
Charlotte S Wilhelm, Karl T Kelsey, Rondi Butler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
O Sartor, R E Coleman, S Nilsson, et al.
European Journal of Pain (London, England)
|
August 28, 2015
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
P Marchettini, S Wilhelm, H Petto, et al.
British Journal of Cancer
|
October 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer
Frances Willenbrock, Catrin M Cox, Eileen E Parkes, et al.
Histopathology
|
March 12, 2014
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
David P Boyle, Darragh G McArt, Gareth Irwin, et al.
The Journal of Clinical Investigation
|
April 29, 1998
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity
Y Zhang, H Weiler-Guettler, J Chen, et al.
British Journal of Cancer
|
March 29, 2017
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study
David L Phelps, Jane V Borley, Kirsty J Flower, et al.
BMJ Open
|
December 8, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes
Charlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber, et al.
Leukemia
|
October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach
T Burmeister, J Maurer, M Aivado, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Environmental Health Perspectives
|
October 19, 2011
In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta
Charlotte S Wilhelm-Benartzi, E Andres Houseman, Matthew A Maccani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Implications of LINE1 methylation for bladder cancer risk in women
Charlotte S Wilhelm, Karl T Kelsey, Rondi Butler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
O Sartor, R E Coleman, S Nilsson, et al.
European Journal of Pain (London, England)
|
August 28, 2015
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
P Marchettini, S Wilhelm, H Petto, et al.
British Journal of Cancer
|
October 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer
Frances Willenbrock, Catrin M Cox, Eileen E Parkes, et al.
Histopathology
|
March 12, 2014
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
David P Boyle, Darragh G McArt, Gareth Irwin, et al.
The Journal of Clinical Investigation
|
April 29, 1998
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity
Y Zhang, H Weiler-Guettler, J Chen, et al.
British Journal of Cancer
|
March 29, 2017
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study
David L Phelps, Jane V Borley, Kirsty J Flower, et al.
BMJ Open
|
December 8, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes
Charlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber, et al.
Leukemia
|
October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach
T Burmeister, J Maurer, M Aivado, et al.
Page
of 17